Zydus Cadila gets USFDA nod for multiple sclerosis treatment drug
NE BUSINESS BUREAU NEW DELHI, SEPT 25 Drug firm Zydus Cadila on Friday said it has received final approval from the US health regulator to market Dimethyl Fumarate delayed-release capsules, indica…
